The expert jury selected Dragan Grabulovski, Ph.D., Philipp Spycher, Ph.D., and Isabella Attinger-Toller, Ph.D. of Araris ...

The mood is better than the numbers suggest. The doom-loop panic of March and April is behind us, even though the XBI has ...

Viking Therapeutics (VKTX 1.70%) is developing VK2735, a dual GLP-1/GIP receptor agonist for obesity treatment. The company ...

The National Biotechnology Research and Development Agency (NBRDA) has said biotechnology is more relevant than ever, ...

The EU Commission has set aside €350M in funding opportunities to boost food and biotech innovation, highlighting the ...

Drug pricing in the US is firmly back in the political spotlight. In May, President Donald Trump revived the idea of a ...

During a House Energy Committee hearing last week, Rep. Thomas Kean (R-NJ) asked Health and Human Services Secretary Robert F ...

"If a company isn't IPO-ready, it better be M&A-ready," says Nanna Luneborg of Forbion Capital Partners. She and co-founder Sander Slootweg sit down with Bloomberg Intelligence analyst Sam Fazeli to ...

There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific ...

Arsenale Bioyards recognized the inefficiencies and developed a platform that could radically change biomanufacturing, much like the Bessemer converter in the mid-19th century transformed the steel ...

A memo that purports to summarize a meeting held by members of a biotech trade group suggests deep concern about RFK Jr.’s ...

A European pharma trade organisation has said that a new strategy launched by the EU to bolster the region's standing in life ...